Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis.

@article{DescampsLatscha1993SolubleCA,
  title={Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis.},
  author={Béatrice Descamps-Latscha and Andr{\'e} Herbelin and Anh Thu Nguyen and Donat de Groote and Ph Chauveau and Claude Verger and Paul Jungers and Johanna Zingraff},
  journal={Kidney international},
  year={1993},
  volume={43 4},
  pages={
          878-84
        }
}
Patients with chronic renal failure often present an immunodeficiency state paradoxically exacerbated by hemodialysis and associated with signs of T cell activation. The presence of circulating monokines suggests that monocytes are also activated. Whether or not this includes B cells is controversial, despite frequently abnormal antibody responses. We thus investigated whether the soluble low-affinity receptor for IgE (Fc epsilon RII/CD23), recently identified as a marker of B cell and monocyte… 

Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients

TLDR
The highly elevated levels of sCD40 may point to the involvement of CD40 and its ligand CD40L in the clinical manifestation of uraemic immunodeficiency.

Macrophage colony stimulating factor involvement in uremic patients.

TLDR
The results suggest that M-CSF may play a role in altering the immune system in uremic patients by maintaining in the circulation and tissues permanently primed monocytes and/or macrophages that can then be triggered to an activated state by secondary stimuli such as endotoxins, complement components, other cytokines or contact with foreign surfaces.

Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.

TLDR
The group of 27 patients with severe ARF who needed IHD, showed increased plasma concentrations of some leukocyte, platelet and endothelial activation markers that characterize the inflammatory and procoagulant state associated with this pathologic condition.

Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.

TLDR
The results demonstrate an enhanced expression of CD14 by monocytes after HD and increased sCD14 serum levels possibly due to chronic exposure to trace amounts of endotoxins, as supported by in vitro experiments.

Leukocyte, Platelet and Endothelial Activation in Patients with Acute Renal Failure Treated by Intermittent Hemodialysis

TLDR
The group of 27 patients with severe ARF who needed IHD, showed increased plasma concentrations of some leukocyte, platelet and endothelial activation markers that characterize the inflammatory and procoagulant state associated with this pathologic condition.

Cellular Immunity and Levels of Parathyroid Hormone in Uremic Patients Receiving Hemodialysis

TLDR
The elevated level of PTH seems to affect the lymphocyte function and is associated with changes in cellular immunity in the hemodialysis population, which will lead to more solid conclusions.

Effect of parathyroid hormone on cellular immunity in uremic patients undergoing peritoneal dialysis

TLDR
Elevated PTH seems to affect lymphocyte function and is associated with changes in cellular immunity in a peritoneal dialysis population.

Platelet Activity and Serum Homocysteine Levels in Patients with End-Stage Renal Failure with Regard to Dialysis Modality

TLDR
Hemodialysis and peritoneal dialysis have a different impact on the expression of CD62: peritoneAL dialysis seems to have a more favorable effect, and it may be possible that the differences in biocompatibility between PD and HD potentially contribute to differences in CD62 expression.

Serum Concentration of IL-2, IL-6, TNF-Alpha and Their Soluble Receptors in Children on Maintenance Hemodialysis

TLDR
The data suggest that immune cells in HD children are in an activated state and that neither a single dialysis session nor the type of dialyzer membrane has an influence on the cytokines examined.

Role of cytokines in the response to erythropoietin in hemodialysis patients.

TLDR
A previously undescribed pattern of cytokine alteration that is relevant to determine increased needs of EPO in hemodialysis patients is disclosed and has potential applicability in designing strategies to improve EPO resistance.
...

References

SHOWING 1-10 OF 46 REFERENCES

Elevated circulating levels of interleukin-6 in patients with chronic renal failure.

TLDR
Plasma IL-6 activity was significantly increased in patients with chronic renal failure and that of tumor necrosis factor alpha in both long-term and not yet dialyzed uremic patients, and a close correlation existed between the biological activity ofIL-6 and its immunoreactive level.

In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.

TLDR
A similar pattern of T cell abnormalities was observed in the uremic non-hemodialyzed patients studied, and a significantly decreased IL-2 activity was detected in the supernatants of stimulated T cells from hemodialyzing patients.

In vitro characterization of immunological responsiveness of uremic patients.

TLDR
It was found that PHA and LPS responses were reduced in cells from the patient group compared to the control group and MLC responsiveness using pooled stimulator cells and polyclonal antibody secretion induced by Staphylococcus aureus bacteria in vitro was reduced in the patients.

Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.

TLDR
This study confirms the participation of lymphocytes in the complex blood-membrane interactions that occurs during dialysis; the results may be relevant to observations of immune deficiency in dialysis patients.

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.

TLDR
The concomitant presence of IL-1 and TNF alpha in the plasma of long-term HD patients could be responsible for some of the clinical features observed in these patients, and provides strong evidence favoring the concept that HD can be assimilated to a recurrent acute-phase inflammatory response.

B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.

TLDR
It is concluded that B-cell activation and immunoregulation is defective in patients undergoing long-term hemodialysis.

Respective influence of uremia and hemodialysis on whole blood phagocyte oxidative metabolism, and circulating interleukin-1 and tumor necrosis factor.

TLDR
Several hypotheses have been put forward to explain this state of immunodeficiency associated with chronic uremia and the changes in humoral and cellular immunity related to the hemodialysis procedure.

Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study.

TLDR
This study confirms that, coincident with the nadir of leukopenia observed at T15, dialysis with CUP but not PAN membranes induces a marked rise in C3a antigen levels and profound alterations in whole blood CL production consisting of a dramatic increase in basal CL and a significant loss in CL response capacity to stimulating agents.

Complement activation and hypersensitivity reactions to dialysis membranes.

TLDR
The occurrence of adverse symptoms associated with new cuprophane-membrane dialyzers correlates with complement activation, and patients with the first-use syndrome have maximal complement activation 10 minutes after initiation of dialysis.

Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis.

TLDR
This study investigated whether mononuclear cells bearing receptors for interleukin 2 (IL-2R+ MNC) were present within glomeruli or associated crescents in biopsies from patients with crescentic glomerulonephritis, particularly in cases of IgA disease featuring crescent formation.